Find weekly COMPPARE activation and enrollment updates here.

The following meters are reported as of 7/31/20:

• The COMPPARE Consortium has activated 100% of the 45 partner sites that will enroll patients.
• Patient Enrollment. The COMPPARE study will enroll 1500 patients receiving photon therapy and 1500 patients receiving proton therapy. As of 7/31/20, COMPPARE has enrolled 736 participants, or 24.5% of goal.
• Current Enrollment Breakdown The current RCT, current photon, and current pragmatic proton enrollments. As of 7/31/20, COMPPARE has enrolled 136 photon participants (18%), 197 RCT proton participants (27%), and 403 (55%) pragmatic proton participants.